Dima Kozakov

Dima Kozakov develops computational tools that integrate physics, AI and biology to transform drug design and improve understanding of disease mechanisms. Software he developed is widely used by pharmaceutical companies worldwide, particularly in cancer therapeutics. Jointly appointed in UT’s Oden Institute for Computational Engineering and Sciences as the W.A. “Tex” Moncrief, Jr. Chair in Computational Life Sciences and Biology, Kozakov is launching a new research center focused on using artificial intelligence and deep learning to model molecular interactions and predict therapeutic effects in cancer research, with support from the Cancer Prevention and Research Institute of Texas (CPRIT). He was named a Clarivate Highly Cited Researcher in 2024, and his CLUSPRO web server is consistently ranked among the top tools for modeling biomolecular interactions, serving more than 40,000 academic users globally. He joined UT after serving on the faculty at Stony Brook University. He received his master’s in applied mathematics and physics from the Moscow Institute of Physics and Technology and his Ph.D. in biomedical engineering from Boston University.